Operations Research Techniques in Cancer Treatment

Yönetim bilimi olarak da bilinen yöneylem araştırması, daha iyi kararlar vermek amacıyla ileri analitik yöntemlerin uygulanması disiplini olarak tanımlanabilir. Yöneylem araştırması kanser tedavilerindeki karar süreçlerini de başarılı bir şekilde desteklemektedir. Bu çalışma, söz konusu çerçevede, mevcut durum hakkında bir fikir vermeyi ye kanser tedavileri ile yöneylem araştırmasımn bileşimini kısaca tanımlamayı amaçlamaktadır. Bu sinerjik alanda son zamanlarda artan sayıda araştırmalar ohnasma karşın, yine de keşfedilmeyi bekleyen bir boşluk olduğu söylenebilir. Bu disiplinler arası yaklaşımın çıktıları kanser klinisyenlerince kullanılabilir.
Anahtar Kelimeler:

radyoterapi, optimizasyon

Kanser Tedavisinde Yöneylem Araştırması Teknikleri

Operations research, also known as management science, can be defined as the discipline of applying advanced analytical methods to help make better decisions. It successfully enhances the decision processes of cancer treatment. This study aims to give an idea about state-of-the-art and a brief description of the combination of operations research techniques and cancer therapies. Although there is recently an increase of researches in this synergistic area, there is still a blank to be discovered. The outcomes of this interdisciplinary approach may be utilized by cancer clinicians.

___

  • American Cancer Society, 06/29/2006, Types of treatment, http://www.cancer.org/docroot/ETO/ETO_ l.asp?sitearea=ETO. Ann Oper Res March., 2003.
  • BORTFELD T., CHEN GTY., 2004, "Introductiomlntrafractional organ motion and its management', Semin Radiat Oncol., 14:1, p. 1.
  • BRANDEAU M., SAINFORT F., PIERSKALLA W., editors,, 2004, Operations research and health care: A handbook of methods and applications, Norwell MA:Kluwer Academic Publishers.
  • Center for Operations Research in Medicine, 06/29/2006, http://www2.isye.gatech.edu/~evakylee/ medicalor/
  • CHUI CK, CAI Y., WANG Z., et al., 2006, "Flow visualization for interactive simulation of drugs injection during chemoembolization", Stud Health Technol Inform., 119, pp. 99-101.
  • ÇETİN E,, 2007, "Handling organ motion in radiotherapy of cancer via Markov chains", Appl Math Comput., 184,2, pp. 149-155.
  • DALE, R., CARABE-FERNANDEZ A., 2005, "The radiobiology of conventional radiotherapy and its application to radionuclide therapy", Cancer Biother Radiopharm., 20:1, pp. 47-51.
  • DEWARAJA, YKL, WILDERMAN SJ., LJUNGBERG M, et al., 2005, "Accurate dosimetry in 1311 radionucleid therapy using patient-specific 3- dimensional methods for SPECT reconstruction and absorbed dose calculation", J Nucl Med., 46:5, pp. 840-47.
  • ESEN Ö., ÇETİN E., TOLUN ESEN S., 26-27 May 2006, "Operations research techniques in medicine and selected applications", Proceedings of H. Congress of Medical Biological Sciences, Istanbul, Istanbul University Cerrahpaşa School of Medicine (a national congress).
  • ESEN ö., ÇETİN E., TOLUN ESEN S., 2006, "A mathematical immunochemoradiotherapy model: A multiobjective approach", Nonlinear Analysis: Real World Applications., Article in Press, available from www.elsevier.com/locate/nonrwa.
  • EXPOSITO J., HERNANDEZ J., FEIJOO AF., et ai., 2003, "New chemotherapy treatments in advanced cancer patientsiAn easily applicable evaluation of clinical efficacy and cost-effectiveness", Acta Oncol, 42:8, pp. 895-902.
  • FYMAT AL., GREENFIELD MA., Lo SC, et al., 1998, "Optimization of the radiotherapy treatment plan", Appl Math Comput., 27:2, pp. 117-146.
  • HAMACHER HW., KÜFER KH., 2002, "Inverse radiation therapy planning-a multiple objective optimization approach", Discrete Appl Math., 118, pp. 145-161.
  • Institute for Operations Research and Management Sceinces (INFORMS), 06/26/2006, "Identifying and neutralizing the cause of deadly side effects of Eli Lilly&Co anticancer drug ALIMTA", www.sciencepfbetteriorg.
  • Institute for Operations Research and Management Sceinces (INFORMS), 06/26/2006, "What operations research is", www.scienceofbetter.org.
  • KARNON J., BROWN J., 1998, "Selecting a decision model for economic evaluation: a case study and review", Health Care Manag Set, 1:2, pp. 133-140.
  • KONSKI A., WATKINS-BRUNER D., 2004, "RTOG (Radiation Therapy Oncology Group) Outcomes Model, The RTOG outcomes model: economic end points and measures", Expert Opin Pharmacother., 5:3, pp. 513-519.
  • KONSKI A., WATKINS-BRUNER D., BRERETON H., et al., 2006, "Long-term hormone therapy and radiation is cost-effective for patients with locally advanced prostate carcinoma", Cancer, 1:106, pp: 51-57.
  • LANGER M., BROWN R., URÎE M., et al., 1990, "Large-scale optimization of beam weights under dose-volume restrictions", Int J Radiat Oncol Biol Phys., 18:4, pp. 887-893.
  • LEE EK., CHA K., BORTFELD T., et al., 2005, "Multistage treatment planning optimization for managing organ motion in radiotherapy planning, Proceedings of the 47th Annual ASTRO Meeting", Int J Radiat Oncol Biol Phys., 63 (Suppl):2.
  • LEE EK., FOX T., CROCKER I., 2000, ''Optimization of radiosurgery treatment planning via mixed integer programming", Med Phsy., 27, pp. 995-1004.
  • LEE EK., FOX T., CROCKER I., 2003, "Integer programming applied to intensity-modulated radiation treatment planning", Ann Oper Res., 119, pp.165-181.
  • LIANG Y., LEUNG KS., MOK TS., 2006, "A novel evolutionary drug scheduling model in cancer chemotherapy", IEEE Trans Inf Technol Biomed., 10:2, pp. 237-245.
  • LUNDKVIST J., EKMAN M., ERICSSON SR., et al., 2005, "Economic evaluation of proton radiation therapy in the treatment of breast cancer", Radiother Oncol., 75:2, pp. 179-185.
  • MATTHIAS E., 2005, Multicriteria optimization, 2nd ed., Germany, Springer.
  • MURRAY JD., 2003, Mathematical biology II:Spatial models and biomedical applications, 3rd ed., USA, Springer.
  • NCI-NSF, Feb 7-9, 2002, "Operations research applied to radiation therapy", http://www2.isye.gatech.edu/ncinsf.orart2002/, 06/28/2006.
  • PAGANETTI H., JIANG H., APAMS JA., et al., 2004, "Monte Carlo simulations with time-dependent geometries to investigate effects of organ motion with high temporal resolution", Int J Radiat Oncol Biol Phys., 60:3, pp. 942-950.
  • PREZIOSIL., 2003, Cancer modeling and simulation, USA:Chapman & Hall/ CRC.
  • PUTERMAN ML., SCHUMACHER P., SANDOR GG., 1990, "Optimal choice of prognostic variables with an application to cardiac monitoring using Mmode echocardiography", Stat Med., 9:3, pp. 273-286.
  • QI X., 2006, "Stochastic models for prodrug targeting. 1. diffusion of the efflux drug", Mol Pharm., 3:2, pp. 187-195.
  • REDPATH AT., VICKERY BL., WRIGHT DH., 1975, "A set of Fortran subroutines for optimizing radiotherapy plans", Comput Programs Biomed., 5:2, pp. 158-164.
  • ROMEIJN HE., AHUJA RK., DEMPSEY JF., et al., 2006, "A new linear programming approach to radiation therapy treatment planning problems", Oper Res., 54:2, pp. 201-216.
  • SGOUROS G., 2005, "Dosimetry of internal emmiters", J Nucl Med., 46 (1 Suppl):18S.
  • SHAHINE BH., LI JS., LEE MC, et al., 2001, "Energy and intensity modulated protons beams:A Monte Carlo dosimetry study", Int J Radiat Oncol Biol Phys., 51(1 Suppl):3, p. 404.
  • SOFER A., ZENG J., 2002, "Optimized Needle biopsy strategies for prostate cancer detection", In;, Pardalos PM., Principe J., editors, Biocomputing, pp. 45-61.
  • SOFER A., ZENG J., MUN SK., 2003, "Optimal biopsy protocols for prostate cancer", Ann Oper Res., 119, pp. 63-74.
  • VAN HERK M., 2004, "Errors and margins in radiotherapy", Semin Radiat Oncol., 14:1, pp. 52-64.
  • YU Y., 1997, "Multiobjective decision theory for computational optimization in radiation therapy", Med Phys., 24, pp. 1445-1454.